JOHN PALMER: Open Payments
NPI 1851951818 · ELIZABETHTOWN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$462 in 24 payments from 8 companies in 2025. Trend: 2023 $734 · 2024 $999 · 2025 $462
Food & beverage: $462
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $218 |
| Axsome Therapeutics, Inc. | 4 | $74 |
| Alkermes, Inc. | 3 | $53 |
| Biogen, Inc. | 2 | $51 |
| Neurocrine BioSciences, Inc. | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Tris Pharma Inc | 1 | $15 |
| Vanda Pharmaceuticals Inc. | 1 | $14 |
Products named: VRAYLAR, Auvelity, LYBALVI, ZURZUVAE, INGREZZA, TRINTELLIX, Dyanavel XR, FANAPT.
Industry payments across KY — which companies pay providers there.
